title: Infection of continuous subcutaneous insulin infusion site with Mycobacterium peregrinum.
authors.forename: C
authors.initials: C
authors.lastname: Pagnoux
authors.forename: X
authors.initials: X
authors.lastname: Nassif
authors.forename: C
authors.initials: C
authors.lastname: Boitard
authors.forename: J
authors.initials: J
authors.lastname: Timsit
mesh_terms: D000038:Abscess / Q000209:etiology / Q000382:microbiology*; D000328:Adult; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D007332:Insulin Infusion Systems / Q000009:adverse effects*; D009161:Mycobacterium / Q000145:classification* / Q000302:isolation & purification; D009164:Mycobacterium Infections / Q000209:etiology*
chemical_list: D007004:Hypoglycemic Agents